n-acetylsphingosine has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ayub, M; Bae, JS; Jin, HK | 1 |
| Arboleda, G; Arboleda, H; Sánchez-Mora, RM | 1 |
| Arboleda, G; Fernyhough, P; Gibson, RM; Huang, TJ; Verkhratsky, A; Waters, C | 1 |
1 review(s) available for n-acetylsphingosine and Parkinson Disease
| Article | Year |
|---|---|
Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Topics: Alzheimer Disease; Central Nervous System; Ceramides; Eicosanoids; Forecasting; Homeostasis; Humans; Inflammation; Lipoxygenase; Lysophospholipids; Membrane Lipids; Models, Biological; Nerve Degeneration; Neurodegenerative Diseases; Neuroglia; Neurons; Parkinson Disease; Phosphotransferases (Alcohol Group Acceptor); Prostaglandin-Endoperoxide Synthases; Sphingolipids; Sphingosine | 2021 |
2 other study(ies) available for n-acetylsphingosine and Parkinson Disease
| Article | Year |
|---|---|
PINK1 overexpression protects against C2-ceramide-induced CAD cell death through the PI3K/AKT pathway.
Topics: Cell Death; Cell Line; Cell Survival; Humans; Mitochondrial Membranes; Parkinson Disease; Phosphatidylinositol 3-Kinases; Protein Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Sphingosine | 2012 |
Insulin-like growth factor-1-dependent maintenance of neuronal metabolism through the phosphatidylinositol 3-kinase-Akt pathway is inhibited by C2-ceramide in CAD cells.
Topics: Animals; Apoptosis; Brain; Cell Differentiation; Cell Line, Tumor; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Energy Metabolism; Glycolysis; Insulin-Like Growth Factor I; Membrane Potential, Mitochondrial; Mesencephalon; Mice; Nerve Degeneration; Neurons; Parkinson Disease; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Sphingosine | 2007 |